Xizang Haisco Pharmaceutical Group Co Ltd (002653) — Capital Reinvestment Ratio
Xizang Haisco Pharmaceutical Group Co Ltd (002653) has a Capital Reinvestment Ratio of 1.83x as of September 2025, meaning it reinvests 2% of its operating cash flow (CN¥39.68 Million) in capital expenditures (CN¥72.46 Million). See 002653 equity to assets ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Xizang Haisco Pharmaceutical Group Co Ltd Capital Reinvestment Ratio (2008–2024)
This chart tracks Xizang Haisco Pharmaceutical Group Co Ltd's Capital Reinvestment Ratio across 17 annual periods. Check Xizang Haisco Pharmaceutical Group Co Lt total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Xizang Haisco Pharmaceutical Group Co Ltd (2008–2024)
Year-by-year Capital Reinvestment Ratio for Xizang Haisco Pharmaceutical Group Co Ltd from 2008 to 2024. For live market cap and broader valuation context, see 002653 stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.00x | CN¥442.05 Million | CN¥440.65 Million | ▲ +14.6% |
| 2023 | 0.87x | CN¥449.58 Million | CN¥391.01 Million | ▼ -88.3% |
| 2022 | 7.41x | CN¥94.55 Million | CN¥700.17 Million | ▼ -62.3% |
| 2021 | 19.63x | CN¥35.80 Million | CN¥702.94 Million | ▲ +572.9% |
| 2020 | 2.92x | CN¥206.21 Million | CN¥601.72 Million | ▲ +282.7% |
| 2019 | 0.76x | CN¥764.26 Million | CN¥582.68 Million | ▲ +2.4% |
| 2018 | 0.74x | CN¥472.61 Million | CN¥351.98 Million | ▼ -25.8% |
| 2017 | 1.00x | CN¥391.81 Million | CN¥393.26 Million | ▲ +105.4% |
| 2016 | 0.49x | CN¥426.11 Million | CN¥208.24 Million | ▼ -23.7% |
| 2015 | 0.64x | CN¥443.03 Million | CN¥283.68 Million | ▲ +37.0% |
| 2014 | 0.47x | CN¥502.57 Million | CN¥234.86 Million | ▲ +62.0% |
| 2013 | 0.29x | CN¥568.41 Million | CN¥163.98 Million | ▲ +7.0% |
| 2012 | 0.27x | CN¥464.75 Million | CN¥125.30 Million | ▼ -40.3% |
| 2011 | 0.45x | CN¥260.79 Million | CN¥117.72 Million | ▲ +104.9% |
| 2010 | 0.22x | CN¥367.38 Million | CN¥80.95 Million | ▲ +237.9% |
| 2009 | 0.07x | CN¥368.21 Million | CN¥24.01 Million | ▼ -83.5% |
| 2008 | 0.40x | CN¥94.45 Million | CN¥37.38 Million | — |